尿溶性CD163水平与IgA脏病的疾病活动和治疗反应的相关性
Jingyi Li1,2,3, Jicheng Lv1,2,3, Muh Goet Wong4,5,6
1Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
尿溶性CD163 (u-sCD163) 是IgA脏病 (IgAN) 患者的一个有前途的非侵入性生物标志物. 较高的u-sCD163水平表明,皮质类固醇治疗的益处更大,病进展风险降低.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 皮质类固醇对IgA脏病 (IgAN) 有效,但存在风险.
- 识别那些从类固醇中受益最多的患者需要非侵入性生物标志物.
- 尿溶性CD163 (u-sCD163) 是替代激活巨细胞的标记物,可以预测治疗反应.
研究的目的:
- 调查u-sCD163与Igan.an对皮质类固醇治疗的反应之间的关联.
- 评估u-sCD163作为IGAN的非侵入性生物标志物.
主要方法:
- 从大型队列和TESTING试验的Igan患者中测量了u-sCD163.
- 相关的基线和序列u-sCD163水平与皮质类固醇治疗反应和结局.
主要成果:
- u-sCD163水平与脏巨细胞透和活跃病变相关.
- 较高的基线u-sCD163与较大的蛋白尿缓解与皮质类固醇有关.
- 皮质类固醇治疗降低了u-sCD163水平,这种降低与较低的进展风险相关.
结论:
- u-sCD163是一种可靠的IgAN的非侵入性生物标志物.
- u-sCD163与活跃的病理有关,可以帮助指导葡萄糖皮质激素治疗决策.
更多相关视频
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
相关概念视频
Urine Studies I: Urinalysis
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Nephrotic Syndrome II : Assessment and Medical Management
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Calculi III: Medical Management
